These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 3862669

  • 1. Amiloride in differentiation and commitment of Friend erythroleukemia cells.
    Lubin M.
    J Cell Physiol; 1985 Sep; 124(3):539-44. PubMed ID: 3862669
    [Abstract] [Full Text] [Related]

  • 2. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J.
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [Abstract] [Full Text] [Related]

  • 3. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E, Reuben RC, Rifkind RA, Marks PA.
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [Abstract] [Full Text] [Related]

  • 4. Alterations in electrophoretic mobility, diaphorase activity, and terminal differentiation induced in murine erythroleukemia lines by differentiating agents.
    Gascoyne PR, Becker FF.
    J Cell Physiol; 1990 Feb; 142(2):309-15. PubMed ID: 2303526
    [Abstract] [Full Text] [Related]

  • 5. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
    Tsiftsoglou AS, Sartorelli AC.
    Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
    [Abstract] [Full Text] [Related]

  • 6. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 7. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR, Singh LP, Wahba AJ.
    Exp Hematol; 1995 Oct 01; 23(11):1204-11. PubMed ID: 7556531
    [Abstract] [Full Text] [Related]

  • 8. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS, Wong W.
    Anticancer Res; 1985 Oct 01; 5(1):81-99. PubMed ID: 3888045
    [Abstract] [Full Text] [Related]

  • 9. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
    Fioritoni G, Bertolini L, Torlontano G, Revoltella R.
    Cancer Res; 1980 Mar 01; 40(3):866-72. PubMed ID: 6937242
    [Abstract] [Full Text] [Related]

  • 10. Effects of depletion of intracellular tetrahydrobiopterin in murine erythroleukemia cells.
    Zhuo S, Fan S, Kaufman S.
    Exp Cell Res; 1996 Jan 10; 222(1):163-70. PubMed ID: 8549660
    [Abstract] [Full Text] [Related]

  • 11. Polyamine biosynthesis enzymes in the induction and inhibition of differentiation in Friend erythroleukemia cells.
    Gazitt Y, Friend C.
    Cancer Res; 1980 May 10; 40(5):1727-32. PubMed ID: 6154532
    [Abstract] [Full Text] [Related]

  • 12. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
    Sherman ML, Shafman TD, Kufe DW.
    J Cell Physiol; 1988 Mar 10; 134(3):429-36. PubMed ID: 2450878
    [Abstract] [Full Text] [Related]

  • 13. Early inhibition of phospholipid synthesis in dimethyl sulfoxide (DMSO) treated Friend erythroleukemia (FL) cells.
    Harel L, Lacour F, Friend C, Durbin P, Semmel M.
    J Cell Physiol; 1979 Oct 10; 101(1):25-32. PubMed ID: 295286
    [No Abstract] [Full Text] [Related]

  • 14. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells.
    Ardman B, DiMambro E, Levy SB, Schwartz RS.
    J Immunol; 1987 Sep 15; 139(6):2038-43. PubMed ID: 3476672
    [Abstract] [Full Text] [Related]

  • 15. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan 15; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 16. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH, Friedman H.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):105-10. PubMed ID: 3859684
    [Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of a subline of Friend erythroleukemia cells that differentiate in tissue culture in the absence of inducers.
    Rovera G, Surrey S.
    Cancer Res; 1977 Nov 15; 37(11):4211-9. PubMed ID: 269014
    [No Abstract] [Full Text] [Related]

  • 18. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism.
    Tsiftsoglou AS, Mitrani AA, Housman DE.
    J Cell Physiol; 1981 Sep 15; 108(3):327-35. PubMed ID: 6793604
    [Abstract] [Full Text] [Related]

  • 19. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T, Sherman M, Shafman T, Iwata T, Kufe D.
    J Cell Physiol; 1986 Jun 15; 127(3):480-4. PubMed ID: 3458709
    [Abstract] [Full Text] [Related]

  • 20. Amiloride inhibits murine erythroleukemia cell differentiation: evidence for a Ca2+ requirement for commitment.
    Levenson R, Housman D, Cantley L.
    Proc Natl Acad Sci U S A; 1980 Oct 15; 77(10):5948-52. PubMed ID: 6934526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.